Related Experiment Video
Updated: Jun 1, 2026

Transcutaneous Neuromuscular Electrical Stimulation for Treating Varicocele-Induced Scrotal Pain
Published on: August 30, 2024
Does intravesical electrostimulation improve neurogenic constipation? A case report
Rocco Salvatore Calabrò1, Michelangelo Marullo, Giuseppe Gervasi
1IRCCS Centro Neurolesi Bonino-Pulejo, S.S.113 via Palermo, Cda. Casazza, Messina, Italy. salbro77@tiscali.it
Intravesical electrostimulation (IVES) improved bladder emptying in an elderly patient with cauda equina syndrome. Unexpectedly, this treatment also significantly reduced constipation, offering a new therapeutic option.
Area of Science:
- Neurology
- Urology
- Gastroenterology
Background:
- Cauda equina syndrome can lead to significant bladder and bowel dysfunction.
- Impaired bladder emptying is a common complication requiring intervention.
- Constipation is a frequent and debilitating symptom in patients with neurological deficits.
Observation:
- An elderly patient with incomplete cauda equina syndrome received intravesical electrostimulation (IVES) for urinary retention.
- The treatment involved 20 daily sessions of IVES.
- Post-treatment assessment included cistometrography to evaluate bladder function.
Findings:
- IVES treatment resulted in a normalized urinary pattern, improving bladder emptying.
- The patient experienced a significant and unexpected improvement in constipation, with the Wexner score decreasing from 22 to 4.
- This suggests a potential dual benefit of IVES for both urinary and bowel dysfunction.
Implications:
- Intravesical electrostimulation (IVES) presents a viable, less invasive option for managing constipation secondary to spinal and peripheral nerve lesions.
- IVES may offer a novel therapeutic approach for neurogenic bowel dysfunction.
- Further research is warranted to explore the efficacy and mechanisms of IVES in treating constipation in neurological conditions.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management